RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
CNS Biomarkers: Players, products and prospects (Volume II)
Aug 2008 - 110 pages - $1,040
MarketWatch: CNS
Dec 2008 - 25 pages - $200
Company Financials: Alexza Pharmaceuticals
Jan 2010 - $75
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
CNS Market Access in China - Investment in mental health services offers growth opportunities for psychiatry players
Jul 2011 - 98 pages - $5,700
CNS Market Access in India: Government investment into CNS services set to stimulate market growth
Jun 2011 - 99 pages - $5,700
Company Financials: Cephalon, Inc
Jan 2010 - $75
Company Financials: Orexigen Therapeutics, Inc.
Jan 2010 - $75
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us